MedPath

Akorn, Inc.

Akorn, Inc. logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1948-01-01
Employees
2.2K
Market Cap
-
Website
http://www.akorn.com

Clinical Trials

4

Active:0
Completed:4

Trial Phases

1 Phases

Phase 3:4

Drug Approvals

135

FDA:135

Drug Approvals

Pentobarbital Sodium

Approval Date
Feb 1, 2024
FDA

Adenosine

Approval Date
Jan 29, 2024
FDA

Orphenadrine Citrate

Approval Date
Jan 29, 2024
FDA

Adenosine

Approval Date
Jan 29, 2024
FDA

Mycophenolate Mofetil

Approval Date
Jan 26, 2024
FDA

Alfentanil Hydrochloride

Approval Date
Jan 25, 2024
FDA

Mycophenolate Mofetil

Approval Date
Jan 25, 2024
FDA

Phenylephrine Hydrochloride

Approval Date
Dec 18, 2023
FDA

Lorazepam

Approval Date
Feb 13, 2023
FDA

Midazolam

Approval Date
Jan 20, 2023
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (100.0%)

Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris

Phase 3
Completed
Conditions
Acne Vulgaris
Interventions
First Posted Date
2018-05-11
Last Posted Date
2020-10-05
Lead Sponsor
Akorn, Inc.
Target Recruit Count
1125
Registration Number
NCT03522441
Locations
🇺🇸

Site 11, Encino, California, United States

🇺🇸

Site 10, Sherman Oaks, California, United States

🇺🇸

Site 1, Brandon, Florida, United States

and more 9 locations

Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%

Phase 3
Completed
Conditions
Osteoarthritis, Knee
Interventions
First Posted Date
2016-09-23
Last Posted Date
2021-02-26
Lead Sponsor
Akorn, Inc.
Target Recruit Count
934
Registration Number
NCT02913521
Locations
🇪🇪

Vee Family Doctor's Center OY, Paide, Estonia

🇪🇪

OU Mai Perearstid, Parnu, Estonia

🇪🇪

East Tallinn Central Hospital, Tallinn, Estonia

and more 47 locations

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

Phase 3
Completed
Conditions
Head Lice
Interventions
Drug: Placebo
Drug: Benzyl Alcohol Lotion 5%
First Posted Date
2015-12-09
Last Posted Date
2021-01-27
Lead Sponsor
Akorn, Inc.
Target Recruit Count
239
Registration Number
NCT02624843
Locations
🇺🇸

Axis Clinical Trials, Los Angeles, California, United States

🇺🇸

South Florida Family Health and Research Centers (Lice Source Services Inc), Plantation, Florida, United States

An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis

Phase 3
Completed
Conditions
Allergic Conjunctivitis
Interventions
First Posted Date
2012-03-23
Last Posted Date
2013-07-18
Lead Sponsor
Akorn, Inc.
Target Recruit Count
90
Registration Number
NCT01561521
Locations
🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.